Related Experiment Video
Updated: Jun 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated
Karthikeyan Mythreye1, Gerard C Blobe
1Department of Medicine and Pharmacology, Duke University Medical Center, Durham, NC 27708, USA.
Abstract:
Loss of expression of the TGF-beta superfamily coreceptor, the type III TGF-beta receptor (TbetaRIII or betaglycan), occurs in a broad spectrum of human cancers including breast, lung, ovarian, pancreatic, prostate, and renal cell cancer. TbetaRIII suppresses cancer progression in vivo, at least in part, by reducing cancer cell motility. However, the mechanism by which TbetaRIII regulates migration is unknown. Here, we demonstrate an unexpected TGF-beta signaling independent role for TbetaRIII in activating Cdc42, altering the actin cytoskeleton and reducing directional persistence to inhibit random migration of both cancer and normal epithelial cells. Functionally, TbetaRIII through its interaction with the scaffolding protein beta-arrestin2, activates Cdc42 and inhibits migration. These studies identify a TGF-beta independent homeostatic function for TbetaRIII in regulating cell migration.
Insights
The type III TGF-beta receptor (TbetaRIII) suppresses cancer progression by inhibiting cell migration. This study reveals TbetaRIII activates Cdc42 and alters the cytoskeleton, independent of TGF-beta signaling, to reduce cell motility.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Biology
Background:
- Loss of the type III TGF-beta receptor (TbetaRIII), also known as betaglycan, is observed in various human cancers.
- TbetaRIII has been shown to suppress cancer progression by reducing cancer cell motility.
- The precise mechanism by which TbetaRIII regulates cell migration remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which TbetaRIII regulates cancer cell migration.
- To investigate a potential TGF-beta signaling-independent role of TbetaRIII in cell motility.
Main Methods:
- Investigated the role of TbetaRIII in regulating cell migration using both cancer and normal epithelial cells.
- Examined the activation of Cdc42 and alterations in the actin cytoskeleton.
- Studied the interaction between TbetaRIII and beta-arrestin2.
Main Results:
- Demonstrated that TbetaRIII activates Cdc42, leading to changes in the actin cytoskeleton.
- Showed that TbetaRIII reduces the directional persistence of cell migration, inhibiting random cell movement.
- Identified that TbetaRIII activates Cdc42 and inhibits migration through its interaction with beta-arrestin2.
- Confirmed these effects occur independently of TGF-beta signaling.
Conclusions:
- TbetaRIII plays a crucial role in regulating cell migration through a TGF-beta-independent pathway.
- TbetaRIII's interaction with beta-arrestin2 activates Cdc42, impacting the actin cytoskeleton and cell motility.
- This identifies a novel homeostatic function for TbetaRIII in maintaining normal cell migration patterns.
Related Concept Videos
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia

